Table 10.
Outcome in relation treatment of NP group
| Treatment | A n (%) | B n (%) | C n (%) | D n (%) | Total n (%) |
|---|---|---|---|---|---|
| steroids | 2 (3.70) | 1 (1.85) | 0 (0.00) | 0 (0.00) | 3 (5.56) |
| steroids and GTW | 4 (7.41) | 1 (1.85) | 0 (0.00) | 0 (0.00) | 5 (9.26) |
| steroids and MMF | 27 (50.00) | 10 (18.52) | 2 (3.70) | 0 (0.00) | 39 (72.23) |
| steroids and CTX | 2 (3.70) | 2 (3.70) | 0 (0.00) | 0 (0.00) | 4 (7.41) |
| steroids and CsA | 1 (1.85) | 0 (0.00) | 0 (0.00) | 0 (0.00) | 1 (1.85) |
| steroids and FK506 | 2 (3.70) | 0 (0.00) | 0 (0.00) | 0 (0.00) | 2 (3.70) |
| Total | 38 (70.37) | 14 (25.93) | 2 (3.70) | 0 (0.00) | 54 (100.00) |
X 2 = 3.26; P > 0.05
GTW tripterygium glycosides, MMF mycophenolate mofetil, CTX cyclophosphamide, CsA cyclosporine A, FK506 tacrolimus